Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

NCT02669940 · clinicaltrials.gov ↗
COMPLETED
Status
158
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie